N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
申请人:Combs Andrew P.
公开号:US20080214546A1
公开(公告)日:2008-09-04
The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.
N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
申请人:Combs Andrew P.
公开号:US08507541B2
公开(公告)日:2013-08-13
The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.
N-HYDROXYAMIDINOHETEROCYCLIC COMPOUNDS AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
申请人:Incyte Holdings Corporation
公开号:EP2064194B1
公开(公告)日:2018-11-07
US8507541B2
申请人:——
公开号:US8507541B2
公开(公告)日:2013-08-13
[EN] N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE<br/>[FR] N-HYDROXYAMIDINOHÉTÉROCYCLES MODULATEURS DE L'INDOLÉAMINE 2,3-DIOXYGÉNASE
申请人:INCYTE CORP
公开号:WO2008036653A2
公开(公告)日:2008-03-27
[EN] The present invention is directed to N-hydroxyamidino compounds which are modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof. [FR] La présente invention concerne des composés N-hydroxyamidino modulateurs de l'indoléamine 2,3-dioxygénase (IDO), ainsi que des compositions et procédés pharmaceutiques correspondants.